Table 2.
Healthy Controlsa | Schizophrenia Patientsb | |
---|---|---|
Gender (M:F) | 22:14 | 28:14 |
Age | 38.28±11.94 | 39.98±10.10 |
Race (AA:C:other) | 13:21:2 | 16:23:3 |
Education (years) | 15.11±1.91 | 13.05±2.32*** |
Parental education | 14.21±2.08 | 13.55±2.65 |
Haloperidol dose equivalent (mg/day) | — | 10.53±7.85 |
BPRS | — | 37.32±7.09 |
WASI | 118.00±8.63 | 97.83±13.51*** |
MATRICS total | 54.35±8.38 | 30.18±14.13*** |
WRAT-4 | 111.59±13.77 | 96.05±11.39*** |
WTAR | 113.50±10.46 | 98.85±14.26*** |
Note: Abbreviations are explained in the first footnote to table 1.
aCognitive testing is not available for 4 healthy control participants.
bCognitive testing is not available for 2 schizophrenia patients.
***P < .001.